Apellis Pharmaceuticals Inc (NASDAQ:APLS)

28.33
Delayed Data
As of Aug 23
 -1.59 / -5.31%
Today’s Change
11.45
Today|||52-Week Range
30.25
+114.78%
Year-to-Date
No recent news for Apellis Pharmaceuticals Inc.

Today’s Trading

Previous close29.92
Today’s open29.67
Day’s range28.25 - 29.90
Volume242,129
Average volume (3 months)403,586
Market cap$1.8B
Data as of 4:00pm ET, 08/23/2019

Growth & Valuation

Earnings growth (last year)+36.31%
Earnings growth (this year)-70.24%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book9.71

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...-3.35-3.49%
TCDATricida Inc-1.14-3.33%
TPTXTurning Point Therap...+0.39+0.75%
AKCAAkcea Therapeutics I...-0.47-2.16%
Data as of 4:00pm ET, 08/23/2019

Financials

Next reporting dateNovember 12, 2019
EPS forecast (this quarter)-$1.00
Annual revenue (last year)$0.00
Annual profit (last year)-$127.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Cedric Francois
Chief Operating Officer
Pascal Deschatelets
Corporate headquarters
Crestwood, Kentucky

Forecasts